Galectin Therapeutics
GALT
GALT
60 hedge funds and large institutions have $9.26M invested in Galectin Therapeutics in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
21% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 14
23% less capital invested
Capital invested by funds: $12M → $9.26M (-$2.76M)
Holders
60
Holding in Top 10
–
Calls
$185K
Puts
$173K
Top Buyers
| 1 | +$54K | |
| 2 | +$24.5K | |
| 3 | +$19.3K | |
| 4 |
HF
HRT Financial
New York
|
+$19K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$14.8K |
Top Sellers
| 1 | -$227K | |
| 2 | -$161K | |
| 3 | -$104K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$62.5K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$61.6K |